2019 ISNPR实践指南:应用Omega-3脂肪酸治疗抑郁症

2019-09-03 国外精神科相关专家小组(统称) Psychother Psychosom. 2019 Sep 3:1-11.

2019年9月,国际营养精神病学研究学会(ISNPR)发布了应用Omega-3脂肪酸治疗抑郁症的实践指南,抑郁症是一种复杂的精神疾病,其治疗需求尚未得到满足。ω-3 多不饱和脂肪酸的抗抑郁作用已被广泛报道,本文主要针对临床应用Omega-3脂肪酸治疗抑郁症提供实践指导。

中文标题:

2019 ISNPR实践指南:应用Omega-3脂肪酸治疗抑郁症

英文标题:

International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.

发布日期:

2019-09-03

简要介绍:

2019年9月,国际营养精神病学研究学会(ISNPR)发布了应用Omega-3脂肪酸治疗抑郁症的实践指南,抑郁症是一种复杂的精神疾病,其治疗需求尚未得到满足。ω-3 多不饱和脂肪酸的抗抑郁作用已被广泛报道,本文主要针对临床应用Omega-3脂肪酸治疗抑郁症提供实践指导。

 

拓展指南:抑郁相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 ISNPR实践指南:应用Omega-3脂肪酸治疗抑郁症)] GetToolGuiderByIdResponse(projectId=1, id=f34111c001e899f4, title=2019 ISNPR实践指南:应用Omega-3脂肪酸治疗抑郁症, enTitle=International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder., guiderFrom=Psychother Psychosom. 2019 Sep 3:1-11., authorId=null, author=, summary=2019年9月,国际营养精神病学研究学会(ISNPR)发布了应用Omega-3脂肪酸治疗抑郁症的实践指南,抑郁症是一种复杂的精神疾病,其治疗需求尚未得到满足。ω-3 多不饱和脂肪酸的抗抑郁作用已被广泛报道,本文主要针对临床应用Omega-3脂肪酸治疗抑郁症提供实践指导。 , cover=, journalId=null, articlesId=null, associationId=1320, associationName=国外精神科相关专家小组(统称), associationIntro=, copyright=0, guiderPublishedTime=Tue Sep 03 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年9月,国际营养精神病学研究学会(ISNPR)发布了应用Omega-3脂肪酸治疗抑郁症的实践指南,抑郁症是一种复杂的精神疾病,其治疗需求尚未得到满足。ω-3 多不饱和脂肪酸的抗抑郁作用已被广泛报道,本文主要针对临床应用Omega-3脂肪酸治疗抑郁症提供实践指导。 </P> <P> </P>拓展指南:<strong>与<font color=red>抑郁</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=f60fb1c001e0a64d" title="2019 USPSTF建议声明:围产期抑郁的干预和预防" target=_blank>2019 USPSTF建议声明:围产期抑郁的干预和预防</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b152c1c001e0039b" title="2018 ESC意见书:抑郁和冠心病" target=_blank>2018 ESC意见书:抑郁和冠心病</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=fbc051c001698e08" title="2019 临床实践指南:抑郁症与特定精神疾病共病的管理" target=_blank>2019 临床实践指南:抑郁症与特定精神疾病共病的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=2a53f1c0016e30c8" title="阿戈美拉汀治疗抑郁症临床应用专家建议" target=_blank>阿戈美拉汀治疗抑郁症临床应用专家建议</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=680481c001638032" title="2018 NAMS/NNDC指南:围绝经期抑郁的评估和治疗" target=_blank>2018 NAMS/NNDC指南:围绝经期抑郁的评估和治疗</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E6%8A%91%E9%83%81" target=_blank>有关抑郁更多指南</a></ul>, tagList=[TagDto(tagId=3006, tagName=Omega-3脂肪酸), TagDto(tagId=228, tagName=抑郁症)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8008, appHits=288, showAppHits=2, pcHits=3596, showPcHits=5510, likes=48, shares=2, comments=2, approvalStatus=1, publishedTime=Tue Sep 10 22:54:07 CST 2019, publishedTimeString=2019-09-03, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Sep 10 22:54:07 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 01:30:59 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ISNPR实践指南:应用Omega-3脂肪酸治疗抑郁症)])
2019 ISNPR实践指南:应用Omega-3脂肪酸治疗抑郁症
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=901606, encodeId=d2cd9016062a, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/e141ddca670e4042bffbf47e00f8d2fd/b6517df71dfe42cb979aacdc454225cc.jpg, createdBy=0c532181739, createdName=12074e34m25(暂无昵称), createdTime=Mon Nov 23 23:25:24 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803492, encodeId=a92580349213, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acee5401612, createdName=ms7000001773953003, createdTime=Mon Jul 20 15:14:38 CST 2020, time=2020-07-20, status=1, ipAttribution=)]
    2020-11-23 12074e34m25(暂无昵称)

    好好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=901606, encodeId=d2cd9016062a, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/e141ddca670e4042bffbf47e00f8d2fd/b6517df71dfe42cb979aacdc454225cc.jpg, createdBy=0c532181739, createdName=12074e34m25(暂无昵称), createdTime=Mon Nov 23 23:25:24 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803492, encodeId=a92580349213, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acee5401612, createdName=ms7000001773953003, createdTime=Mon Jul 20 15:14:38 CST 2020, time=2020-07-20, status=1, ipAttribution=)]
    2020-07-20 ms7000001773953003

    谢谢

    0